CAC 40 Index Ends 0.69% Lower at 7609.15 — Data Talk
The CAC 40 Index is down 53.15 points or 0.69% today to 7609.15
--Largest one day point and percentage decline since Wednesday, June 19, 2024
--Down for two consecutive trading days
--Down 97.74 points or 1.27% over the last two trading days
--Largest two day point and percentage decline since Monday, June 17, 2024
--Down three of the past four trading days
--Off 7.66% from its record close of 8239.99 hit Wednesday, May 15, 2024
--Lowest closing value since Wednesday, June 19, 2024
--Off 7.66% from its 52-week high of 8239.99 hit Wednesday, May 15, 2024
--Up 11.98% from its 52-week low of 6795.38 hit Friday, Oct. 27, 2023
--Rose 4.43% from 52 weeks ago
--Off 7.66% from its 2024 closing high of 8239.99 hit Wednesday, May 15, 2024
--Up 3.97% from its 2024 closing low of 7318.69 hit Wednesday, Jan. 17, 2024
--Month-to-date it is down 4.80%
--Year-to-date it is up 65.97 points or 0.87%
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 26, 2024 12:37 ET (16:37 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks